Elmwood Wealth Management’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$637K Buy
67,924
+135
+0.2% +$1.27K 0.25% 87
2025
Q1
$482K Buy
67,789
+15
+0% +$107 0.2% 97
2024
Q4
$790K Hold
67,774
0.32% 83
2024
Q3
$1.39M Buy
67,774
+600
+0.9% +$12.3K 0.57% 62
2024
Q2
$1.5M Sell
67,174
-725
-1% -$16.2K 0.67% 57
2024
Q1
$1.87M Sell
67,899
-10
-0% -$275 0.8% 48
2023
Q4
$2.07M Buy
67,909
+10
+0% +$305 1.45% 19
2023
Q3
$2.15M Hold
67,899
1.04% 31
2023
Q2
$2.77M Hold
67,899
1.29% 24
2023
Q1
$2.53M Hold
67,899
1.2% 27
2022
Q4
$2.37M Hold
67,899
1.18% 24
2022
Q3
$3.8M Hold
67,899
1.9% 8
2022
Q2
$3.51M Buy
67,899
+300
+0.4% +$15.5K 2% 11
2022
Q1
$4.91M Buy
67,599
+425
+0.6% +$30.9K 2.52% 5
2021
Q4
$7.94M Buy
+67,174
New +$7.94M 3.79% 2
2021
Q2
$10.9M Hold
67,174
5.73% 1
2021
Q1
$5.39M Buy
+67,174
New +$5.39M 3.29% 4
2020
Q3
$1.35M Hold
64,204
1.09% 28
2020
Q2
$1.35M Buy
64,204
+15,066
+31% +$317K 1.09% 28
2020
Q1
$1.04M Sell
49,138
-15,066
-23% -$318K 0.99% 37
2019
Q4
$942K Sell
64,204
-65,235
-50% -$957K 0.82% 53
2019
Q3
$1.73M Sell
129,439
-3,705
-3% -$49.5K 1.75% 15
2019
Q2
$2.18M Sell
133,144
-3,705
-3% -$60.7K 1.93% 7
2019
Q1
$2.34M Buy
136,849
+75,227
+122% +$1.28M 2.16% 5
2018
Q4
$841K Sell
61,622
-3,705
-6% -$50.6K 0.81% 45
2018
Q3
$1.87M Buy
65,327
+4,985
+8% +$143K 1.55% 17
2018
Q2
$1.65M Buy
60,342
+11,204
+23% +$307K 1.5% 19
2018
Q1
$1.04M Buy
+49,138
New +$1.04M 0.99% 37